Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperazinecarboxylic acid, 4-[(4-bromophenyl)sulfonyl]-, 4-nitrophenyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

203519-23-7

Post Buying Request

203519-23-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

203519-23-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 203519-23-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,5,1 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 203519-23:
(8*2)+(7*0)+(6*3)+(5*5)+(4*1)+(3*9)+(2*2)+(1*3)=97
97 % 10 = 7
So 203519-23-7 is a valid CAS Registry Number.

203519-23-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-bromophenylsulphonyl)-4-(4-nitrophenyloxycarbonyl)piperazine

1.2 Other means of identification

Product number -
Other names 1-(4- bromophenylsulphonyl)-4-(4-nitrophenyloxycarbonyl)piperazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:203519-23-7 SDS

203519-23-7Relevant academic research and scientific papers

Heterocyclic compounds useful as oxido-squalene cyclase inhibitors

-

Page column 14, (2008/06/13)

This invention concerns heterocyclic derivatives of formula (I) which are useful in inhibiting oxido-squalene cyclase, processes for their preparation and pharmaceutical compositions containing them. The present invention is also concerned with heterocyclic derivatives capable of inhibiting cholesterol biosynthesis and hence in lowering cholesterol levels in blood plasma. The present invention also relates to methods of using such heterocyclic derivatives in diseases and medical conditions such as hypercholesterolemia and atherosclerosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 203519-23-7